Results 61 to 70 of about 38,287 (153)

Fc-tagged PLA2R antigen enables high-performance chemiluminescent detection for non-invasive idiopathic membranous nephropathy diagnosis

Talanta Open
Idiopathic membranous nephropathy (IMN) is characterized by anti-phospholipase A2 receptor (PLA2R) antibodies, yet current detection methods lack sensitivity or are invasive. We developed a chemiluminescent assay to address these limitations. Three PLA2R
Jiangjian Liu, Qiong Liang, Yanhang Zhuo, Sunhui Chen   +3 more
doaj   +1 more source

The study of correlation between serum anti-phospholipase A2 receptor antibody and clinicopathology feature and the efficacy in patients with idiopathic membranous nephropathy

Linchuang shenzangbing zazhi, 2020
Objective To assess the correlation between serum anti-phospholipase A2 receptor（PLA2 R） antibody and clinicopathology and the effect of serum anti-phospholipase A2 receptor antibody on the patients with idiopathic membranous nephropathy（IMN）.Methods ...
LI Wen-dong, WANG Jing, ZHANG Yan-qin, WANG Hai-sheng, GAO Ying-ying   +4 more
doaj  

Advances in the pathogenesis and clinical applications of PLA2R-associated membranous nephropathy

Linchuang shenzangbing zazhi
Membranous nephropathy is one of the main pathological types of nephrotic syndrome. PLA2R（phospholipase A2 receptor）associated membranous nephropathy is the predominant type of primary membranous nephropathy， also known as idiopathic membranous ...
Sun Miao-xin, Wang Ding-ding, Wu Hao-wen, Li Yun-xia, Cai Pan-pan, Xin Ye, Chai Wen-xiu, Zhao Xin-cheng, Li Zi-wei, Duan Li-ping   +9 more
doaj  

Anti-phospholipase A2 Receptor Antibody-Negative Membranous Nephropathy in Pregnancy. [PDF]

Cureus, 2023
Saleem M, Iftikhar H.
europepmc   +1 more source

The significance of anti-PLA2R antibody in the diagnosis and treatment of primary membranous nephropathy

Linchuang shenzangbing zazhi, 2019
Primary membranous nephropathy(PMN) is a glomerulus-specific autoimmune disorder mainly caused by challenge of autoantibodies against the recently discovered antigens located on podocytes, such as the M-type phospholipase A2 receptor(PLA2R), the ...
XU Dong-mei, LIU Yi-peng
doaj  

Obinutuzumab in Refractory Phospholipase A2 receptor-Associated Membranous Nephropathy With Severe CKD. [PDF]

Kidney Int Rep, 2023
Naik S, Shukla S, Av N, Kumar V, Sekar A, Nada R, Rathi M, Kohli HS, Ramachandran R.   +8 more
europepmc   +1 more source

Obinutuzumab Treatment in Rituximab- and Bortezomib-Resistant Phospholipase A2 Receptor Antibody-Positive Membranous Nephropathy. [PDF]

Cureus
Yildirim U, Ozkurt S, Yalcin AU.
europepmc   +1 more source

Serum anti-phospholipase A2 receptor antibody in pathological diagnosis of type 2 diabetes mellitus patients with proteinuria. [PDF]

Sci Rep, 2023
Zhang H, Zhu Y, Hu Z, Liu Q.
europepmc   +1 more source

Anti-phospholipase A2 Receptor Membranous Nephropathy Presenting as Common Geriatric Complaints: A Case Report. [PDF]

Cureus
Li WTV, Wu KH, Lin OY.
europepmc   +1 more source

Association of M-Type Phospholipase A2 Receptor Deposition in Kidney Tissue with Treatment Outcomes in Patients with Idiopathic Membranous Nephropathy. [PDF]

J Inflamm Res, 2023
Xie NQ, Zhang YL, Zheng ZL, Zheng QL, Chen RJ.   +4 more
europepmc   +1 more source